openPR Logo
Press release

Acute Care Hospital Bed and Stretcher Market Projections $9.32 Billion by 2034 | Fact.MR

05-20-2024 05:32 PM CET | Health & Medicine

Press release from: Fact.MR

Acute Care Hospital Bed and Stretcher Market

Acute Care Hospital Bed and Stretcher Market

True According to a recently released study report by MR, a provider of competitive intelligence and market research, the global Acute Care Hospital Bed And Stretcher Market (急性期病院用ベッドおよび担架市場) is expected to reach US$ 8.08 billion by 2024. From 2024 to 2034, the demand for stretchers and acute care hospital beds is expected to rise globally at a 1.4% CAGR. Stretchers and acute care hospital beds are in greater demand as a result of the growing population and rising costs for healthcare infrastructure and equipment. Many hospitals invest in cutting-edge, effective patient care equipment to guarantee that patients receive high-quality care.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9123

Key Segments of Acute Care Hospital Bed and Stretcher Industry Research Report:

Elderly people need more specialized medical treatment regularly as they are prone to many disorders due to their weaker immune systems. Acute care stretchers and beds are adapted to match the specific requirements of elderly people. Further, with growing cases of chronic diseases, requirements for continued medical treatment and hospitalization are increasing for the care and management of patients.

Development of technologically advanced acute care hospital beds and stretchers with improved features, including integration with several other medical devices, patient monitoring, and computerized controls is forecasted to open up lucrative opportunities for players.

Key Takeaway from Market Study:

The global acute care hospital bed and stretcher market is forecasted to end up at a valuation of US$ 9.32 billion by 2034.

Revenue from the sales of acute care hospital beds and stretchers is projected to rise at 1.4% CAGR from 2024 to 2034.

Sales of acute care hospital beds and stretchers in the United States are pegged at US$ 1.61 billion in 2024.

Latin America is predicted to hold 11.9% share of global market revenue in 2024.

Revenue from acute care hospital beds and stretchers in Brazil is projected to reach US$ 745.17 million by 2034.

"Growing geriatric population along with rising prevalence of chronic diseases across the globe is predicted to stimulate demand for acute care hospital beds and stretchers as a part of effective healthcare practices," says a Fact.MR analyst.

Asia Pacific to Lead Global Market Growth:

Several countries from Asia Pacific, including China, India, etc. are forecasted to contribute to increased demand for acute care hospital beds and stretchers because of the rising prevalence of chronic diseases. In addition, the presence of many prominent players in the regional countries is also predicted to contribute to market revenue.

Key Market Players:

Leading manufacturers of acute care hospital beds and stretchers are Invacare Corporation, Stryker Corporation, Hill-Rom Holdings Inc., LINET, Paramount Bed Holdings Co., Ltd., Getinge AB, Howard Wright Limited, and Midmark Corp.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9123

By 2034, beds are expected to constitute 86.1% of the global market revenue. Acute care beds, designed for patient accommodation during illness, labor management, and specific injury treatments, play a prominent role. Diverse bed types cater to patient needs, such as tilting beds supporting intensive care unit (ICU) staff in patient care and repositioning for accelerated recovery.

Ensuring optimal protection and comfort, beds aid patients in standing and sitting up swiftly, promoting successful recovery and yielding economic and health benefits. Mobilization beds effectively fulfill this purpose.

Hospitals are anticipated to command a 72.1% share of the global market revenue by 2034. Hospitals prioritize upgrading to advanced acute care hospital beds and stretchers, enhancing functionality and patient care. The replacement of older equipment with specialized and more efficient units is poised to drive increased demand.

Healthcare providers are directing investments toward expanding specialized units like neonatal care, cardiac care, and intensive care, necessitating customized beds and stretchers tailored to specific patient requirements.

Browse Full Report @ https://www.factmr.com/report/acute-care-hospital-bed-and-stretcher-market

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the acute care hospital bed and stretcher market, presenting historical demand data (2018 to 2023) and forecast statistics for the period (2024 to 2034).

The study divulges essential insights into the market based on product type (beds, stretchers) and end user (hospitals, ambulatory surgical centers, and specialty clinics), across six major regions of the world (North America, Europe, East Asia, Latin America, South Asia & Oceania, and MEA).

Checkout More Related Studies Published by Fact.MR Research:

Embolotherapy Market:
https://www.factmr.com/report/embolotherapy-market

Atherectomy Device Market:
https://www.factmr.com/report/atherectomy-device-market

Holter Monitoring System Market:
https://www.factmr.com/report/holter-monitoring-system-market

Oral Solid Dosage Contract Manufacturing Market:
https://www.factmr.com/report/oral-solid-dosage-contract-manufacturing-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Care Hospital Bed and Stretcher Market Projections $9.32 Billion by 2034 | Fact.MR here

News-ID: 3504410 • Views:

More Releases from Fact.MR

Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB Ltd, ANSYS, Inc, AT&T Inc, AVEVA Group plc, Bentley Systems
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 | Fact.MR Report
09-02-2025 | Health & Medicine
Fact.MR
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 2035
09-02-2025 | Health & Medicine
Fact.MR
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.MR Report
09-02-2025 | Health & Medicine
Fact.MR
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.M …
The global fibrin sealants market is valued at USD 976.5 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7%, reaching USD 1.92 billion by 2033. This growth is driven by the increasing prevalence of surgical procedures requiring effective hemostasis and tissue sealing, particularly in cardiovascular, orthopedic, and general surgeries. Fibrin sealants, derived from human plasma proteins, mimic the body's natural clotting process,

All 5 Releases


More Releases for Acute

Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth